Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Evotec & Novo Nordisk: Cell Therapy Tech Development (2024-09-26)
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced to...
NanoVation Tx & Novo Nordisk: up to $600m Partnership (2024-09-18)
> NanoVation will receive research funding and is eligible to receive up to approximately US$600 million in up-front cash and potential milestone payments, as well as tiered royalties on future product sales as part of a multi-year deal > Partnership focuses on ...
Bioké to Distribute Western Blot Imager of e-Blot in Europe (2024-09-16)
BIOKÉ, a leading distributor of life science technologies throughout Europe for more than 20 years and a business unit of Cell Signaling Technology (CST) Europe, has partnered with e-BLOT, a leading supplier of biomedical innovation tools and solutions, to distrib...
IBA’s Joint Venture PanTera Secures €93m Series A Round (2024-09-11)
IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, is pleased to share the below press release from its joint venture PanTera, which is focussed on the production of actinium-225, a novel radioisotope used in a new class of target...
BioArctic: Leqembi (lecanemab) Approved in UK for Early AD (2024-08-22)
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (brand name, generic name: lecanemab) has been granted Marketing Authorization by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain, for the tr...
Adcendo Licenses Rights to ADC Candidate from Multitude Tx (2024-08-20)
Adcendo ApS (“Adcendo”) and Multitude Therapeutics Inc. (“Multitude”) jointly announced today that they have signed a licensing agreement for the development of a novel, highly differentiated antibody-drug conjugate (ADC) targeting Tissue Factor (TF) with t...
Fujifilm Diosynth Opens UK Microbial Manufacturing Facility (2024-08-20)
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, today hosted a celebration for the opening of its microbial fermentation manufacturing ...
Bavarian Nordic: New $156.8m Vaccine Order from US Govt (2024-08-08)
The contract will help replenish inventory of bulk vaccine required for future manufacturing and supply of freeze-dried vaccines. Bavarian Nordic A/S (OMX: BAVA) today announced that it has received a new order valued at USD 156.8 million from the Biomedical A...
Biomatter: €6.5m Seed Round Led by Inventure + UVC Partners (2024-08-05)
Biomatter, a leading enzyme design company, has successfully closed a €6.5 million seed funding round jointly led by Inventure and UVC Partners. In 2019 Biomatter unveiled the first fully functional enzymes created with generative AI in Nature Machine Intelligenc...
Valneva to Receive $41.3m Grant from CEPI and European Union (2024-07-22)
> Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® > Funding will support clinical trials in vulnerable groups, such as children and pregnant women > Partnership will also support techno...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)